Skip to content

The effect of lavender on dialysis patients

The effect of different doses of lavender on the psychological states and physical fatigue in dialysis patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210523051370N5
Enrollment
120
Registered
2021-12-20
Start date
2021-12-22
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients.

Interventions

Intervention 1: Experimental group undergo inhalation of Lavender Angustifolia essential oil with herbarium number 1-133 procured from the Barij Essence Pharmaceutical Company (Kashan, Iran) and store

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years and older Willingness to participate in the study Undergoing dialysis three times a week Ability to communicate Absence of mental disorders No experience of any stressful event in the last 6 months (such as the death of a close relative) Not using sedatives No history of hospitalization due to psychological problems No history of drug and alcohol addiction Dialysis treatment for a minimum of 6 months

Exclusion criteria

Exclusion criteria: Kidney transplant candidates Pregnancy or decision to become pregnant Breastfeeding History of allergies to essential oils and perfumes Acute respiratory disease

Design outcomes

Primary

MeasureTime frame
Anxiety and depression. Timepoint: Before the intervention and the end of the first, second, third, fourth and fifth weeks. Method of measurement: The Hospital Anxiety and Depression Scale.;Fatigue. Timepoint: Before the intervention and the end of the first, second, third, fourth and fifth weeks. Method of measurement: Fatigue Severity Scale.

Secondary

MeasureTime frame
Wellbeing. Timepoint: Before the intervention and the end of the first, second, third, fourth and fifth weeks. Method of measurement: Visual Analog Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Seyed Afshin Shorofi

Mazandaran University of Medical Sciences

arabhoda1364@gmail.com+98 911 676 6280

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026